Nigeria: We Won't Suspend Hydroxychloroquine Trial - Food and Drug Body

allAfrica.com

27 May 2020 0 shares 1 views

Nigeria: We Won't Suspend Hydroxychloroquine Trial - Food and Drug Body

allAfrica.com

Published 27 May 2020

[Premium Times] Barely 24 hours after the World Health Organisation (WHO) suspended all clinical trials for hydroxychloroquine as a potential treatment for COVID-19, the National Agency for Food and Drug Administration and Control (NAFDAC) has said the trial will continue in Nigeria.

Full Article

NA Proactive news snapshot: Matinas BioPharma Holdings, Marrone Bio Innovations, Zynerba Pharmaceuticals, BioPorto, Mawson Resources UPDATE …

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) shares surged in New York on Monday as the company outlined a raft of highlights in its..

Proactive Investors 11 May 2020

NA Proactive news snapshot: Raffles Financial, Thunderbird Entertainment, Zynerba Pharmaceuticals, Codebase Ventures UPDATE …

Raffles Financial Group Limited (CSE:RICH) has announced a strategic partnership with Bank of Montreal’s private Asian bank to..

Proactive Investors 11 May 2020

Nigeria: We Won't Suspend Hydroxychloroquine Trial - Food and Drug Body

Nigeria: We Won't Suspend Hydroxychloroquine Trial - Food and Drug Body

You might like

Related news coverage

NA Proactive news snapshot: Matinas BioPharma Holdings, Marrone Bio Innovations, Zynerba Pharmaceuticals, BioPorto, Mawson Resources UPDATE …

NA Proactive news snapshot: Raffles Financial, Thunderbird Entertainment, Zynerba Pharmaceuticals, Codebase Ventures UPDATE …

Advertisement